However, adjuvant recombinant subunit vaccine tied to more injection site adverse events.
Influenza Vaccines May Protect Against Lab-Confirmed Influenza-Linked Hospitalization During PregnancyNovember 07, 2018
For women who are pregnant, influenza vaccines may moderately protect against laboratory-confirmed influenza-associated hospitalization.
The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.
Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.
14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.
Active Choice Intervention Effective in Increasing Influenza Vaccination Rates at Primary Care PracticesOctober 05, 2018
Influenza vaccination rates decline as the clinic day progresses.
2017 to 2018 flu strains hit the very young and elderly especially hard; poor vaccine/strain match-up.
High population immunity is an indicator of the decline in serotype 2 Sabin vaccine poliovirus after serotype 2 oral poliovirus vaccine withdrawal.
No association was observed between prenatal vaccination of Tdap vaccination and an increased risk of autism spectrum disorder risk in children.
A robust anamnestic response was mounted in most adolescents when challenged with a dose of monovalent HBV vaccine.
Specimens of the rapidly evolving virus are needed to develop vaccines and treatments.
Due to a gap in knowledge regarding serogroup B meningococcal (MenB) disease and vaccination, the majority of clinicians are not discussing MenB vaccines with their adolescent patients during routine visits.
A malaria transmission-blocking vaccine, Pfs25H-EPA in Alhydrogel®, was well tolerated and safe and induced significant blockage of parasite transmission, but this activity was only seen at peak titers after 4 vaccine doses.
For this study, researchers investigated the incidence of primary ovarian insufficiency incidence and estimated risk for POI after vaccination with human papillomavirus, Tdap, influenza and meningococcal conjugate using Kaiser Permanente Northwest electronic health records from 2006 to 2014.
What's the best way to tell your anti-vaccine patients the truth about vaccines?
Immunization with Tdap vaccine during pregnancy results in higher levels of antibodies early in infancy but lower levels after the primary vaccine series.
For adolescents and young adults, the co-administration of quadrivalent meningococcal conjugate vaccine with incorporated tetanus toxoid with diphtheria-tetanus-acellular pertussis vaccine is noninferior to isolated vaccination and does not compromise immunity.
Exemption from vaccination is common in Arizona school districts due to lack of trust in medical establishments.
Inverse association identified between NME rate and MMR vaccine coverage of kindergarteners.
Others have argued that dismissal is ethically problematic because it can deprive children of comprehensive pediatric care and undermine public health.
With the advent of platform manufacturing technology, vaccines can be developed quickly to stop the spread of outbreaks.
The 2017-2018 influenza season in the United States (October 1, 2017-May 19, 2018) was a high-severity season.
The risk of intussusception within 1 to 7 days and 8 to 21 days after rotavirus vaccination was assessed in infants age 28 to 245 days.
Investigators examined parental hesitancy when discussing human papillomavirus vaccination with providers.
In a phase 3 clinical trial, early vaccination effectively prevented herpes zoster in auto-HSCT recipients.
The hexavalent DTPa-HBV-IPV/Hib vaccine may not affect Hib vaccine efficacy.
The CDC recommends 2 doses of the MMR vaccine, which provides 97% protection against measles, prior to international travel.
Clinicians using communication training and fact sheets to inform adolescents about HPV, significantly increased vaccination initiation and completion rates among their patients.
NIH's National Institute of Allergy and Infectious Diseases is researching ways to develop a universal influenza vaccine against multiple strains.
The Advisory Committee on Immunization Practices released updated guidelines to include recommendations for the 3-dose formulation of serogroup B meningococcal vaccine.